Recombinant Human CD40 Ligand Stimulates B Cell Proliferation and Immunoglobulin E Secretion

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1992 Dec 1

PMID 1281209

Citations 94

Authors

M K Spriggs

R J Armitage

L Strockbine

K N Clifford

B M Macduff

T A Sato

C R Maliszewski

W C Fanslow

Affiliations

Soon will be listed here.

Abstract

Signaling through the cell surface molecule, CD40, is known to play an important role in the proliferation and differentiation of B lymphocytes. Using the thymoma cell line EL4, we recently identified and cloned a cDNA encoding a murine ligand for the CD40 molecule (mCD40-L) and showed that it has biological activity in vitro. A cDNA encoding a human homologue of the mCD40-L was isolated using crosshybridization techniques from an activated peripheral blood T cell library. The predicted amino acid sequence indicates that this human ligand for CD40 (hCD40-L) is a 261 amino acid type II membrane protein that exhibits 78% amino acid identity with its murine counterpart. Northern blot and FACS analyses suggest that the hCD40-L is restricted in its expression to T lymphocytes, and that it is most abundant on the CD4+ T cell subpopulation. Cells transfected with hCD40-L caused the proliferation of human tonsil B cells in the absence of costimuli and, in the presence of interleukin 4, induced immunoglobulin E secretion from purified human B cells. A comparison of the efficacy of the hCD40-L and mCD40-L in these assays is presented.

Citing Articles

Cell surface protein-protein interaction profiling for biological network analysis and novel target discovery.

Chen J, Fang M, Li Y, Ding H, Zhang X, Jiang X Life Med. 2025; 3(4):lnae031.

PMID: 39872863 PMC: 11749001. DOI: 10.1093/lifemedi/lnae031.

Stimulation of Angiotensin II Receptor Subtype 2 Reduces Preeclampsia-like Symptoms in a Mouse Model of Preeclampsia.

Matsubara K, Matsubara Y, Uchikura Y, Sugiyama T Curr Issues Mol Biol. 2024; 46(9):9760-9771.

PMID: 39329931 PMC: 11430795. DOI: 10.3390/cimb46090579.

Deciphering Abnormal Platelet Subpopulations in COVID-19, Sepsis and Systemic Lupus Erythematosus through Machine Learning and Single-Cell Transcriptomics.

Qiu X, Nair M, Jaroszewski L, Godzik A Int J Mol Sci. 2024; 25(11).

PMID: 38892129 PMC: 11173046. DOI: 10.3390/ijms25115941.

Developments in kidney xenotransplantation.

Xu H, He X Front Immunol. 2024; 14:1242478.

PMID: 38274798 PMC: 10808336. DOI: 10.3389/fimmu.2023.1242478.

Mechanisms of CD40-dependent cDC1 licensing beyond costimulation.

Wu R, Ohara R, Jo S, Liu T, Ferris S, Ou F Nat Immunol. 2022; 23(11):1536-1550.

PMID: 36271147 PMC: 9896965. DOI: 10.1038/s41590-022-01324-w.

References

Lederman S, Yellin M, Krichevsky A, BELKO J, Lee J, Chess L . Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J Exp Med. 1992; 175(4):1091-101. PMC: 2119166. DOI: 10.1084/jem.175.4.1091. View

Liu Y, Joshua D, Williams G, Smith C, Gordon J, MacLennan I . Mechanism of antigen-driven selection in germinal centres. Nature. 1989; 342(6252):929-31. DOI: 10.1038/342929a0. View

Fanslow W, Anderson D, Grabstein K, Clark E, Cosman D, Armitage R . Soluble forms of CD40 inhibit biologic responses of human B cells. J Immunol. 1992; 149(2):655-60. View

Jabara H, Fu S, Geha R, Vercelli D . CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med. 1990; 172(6):1861-4. PMC: 2188752. DOI: 10.1084/jem.172.6.1861. View

Barrett T, Shu G, Clark E . CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J Immunol. 1991; 146(6):1722-9. View

Uckun F, Schieven G, Dibirdik I, Ledbetter J . Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the Pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. J Biol Chem. 1991; 266(26):17478-85. View

Spriggs M, Lioubin P, Slack J, Dower S, Jonas U, Cosman D . Induction of an interleukin-1 receptor (IL-1R) on monocytic cells. Evidence that the receptor is not encoded by a T cell-type IL-1R mRNA. J Biol Chem. 1990; 265(36):22499-505. View

Paulie S, Rosen A, Jakobson E, Koho H, Perlmann P . The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. J Immunol. 1989; 142(2):590-5. View

Stamenkovic I, Clark E, Seed B . A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 1989; 8(5):1403-10. PMC: 400967. DOI: 10.1002/j.1460-2075.1989.tb03521.x. View

10.

Clark E, Ledbetter J . Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci U S A. 1986; 83(12):4494-8. PMC: 323760. DOI: 10.1073/pnas.83.12.4494. View

11.

Widmer M, Acres R, Sassenfeld H, Grabstein K . Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4). J Exp Med. 1987; 166(5):1447-55. PMC: 2189660. DOI: 10.1084/jem.166.5.1447. View

12.

Southern P, Berg P . Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet. 1982; 1(4):327-41. View

13.

Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, STEIN H . Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell. 1992; 68(3):421-7. DOI: 10.1016/0092-8674(92)90180-k. View

14.

Armitage R, Sato T, Macduff B, Clifford K, Alpert A, Smith C . Identification of a source of biologically active CD40 ligand. Eur J Immunol. 1992; 22(8):2071-6. DOI: 10.1002/eji.1830220817. View

15.

Zhang K, Clark E, Saxon A . CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. J Immunol. 1991; 146(6):1836-42. View

16.

McMahan C, Slack J, Mosley B, Cosman D, Lupton S, Brunton L . A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 1991; 10(10):2821-32. PMC: 452992. DOI: 10.1002/j.1460-2075.1991.tb07831.x. View

17.

Smith C, Davis T, Anderson D, Solam L, Beckmann M, Jerzy R . A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science. 1990; 248(4958):1019-23. DOI: 10.1126/science.2160731. View

18.

Valle A, Zuber C, Defrance T, Djossou O, de Rie M, Banchereau J . Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol. 1989; 19(8):1463-7. DOI: 10.1002/eji.1830190818. View

19.

Torres R, Clark E . Differential increase of an alternatively polyadenylated mRNA species of murine CD40 upon B lymphocyte activation. J Immunol. 1992; 148(2):620-6. View